Last reviewed · How we verify

NCT06238154

Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds

Completed Phase 4 Last updated 26 July 2024
What this trial tests

Phase 4 trial testing Flurbiprofen in Oral Soft Tissue Conditions in 40 participants. Completed in 20 January 2024.

Timeline
26 October 2023
Primary endpoint
12 January 2024
20 January 2024

Quick facts

Lead sponsorYuzuncu Yil University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date26 October 2023
Primary completion12 January 2024
Estimated completion20 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Yuzuncu Yil University

Who can join

Adults 40 to 65, any sex, with Oral Soft Tissue Conditions or Drug Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The amount of active ingredient in tablet form of flurbiprofen is higher than that in the oral spray form. Therefore, based on the hypothesis that the side effects that may occur depending on the dose can be reduced, this clinical study investigated whether tablet and spray form flurbiprofen would have similar effects on postoperative pain in primarily closed soft tissue wounds in the oral region.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the analgesic efficacy of spray and tablet flurbiprofen for pain after soft tissue surgery.
    Eroglu CN, Yuksek MN, Elasan S, Mizrak YR, et al · · 2024 · PMID 39536200 · DOI 10.1590/1807-3107bor-2024.vol38.0108

Verify or expand the search:

Other trials of Flurbiprofen

Trials testing the same drug.

Other recruiting trials for Oral Soft Tissue Conditions

Currently open trials in the same condition.

Other Yuzuncu Yil University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing